The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2020 Euromoney, a part of the Euromoney Institutional Investor PLC.
Capital Markets

US IPO market: Normality? What normality?

There are welcome signs of a recovery of the US IPO market. But an underlying trend is the continuing decline in the number of market debuts by small-cap and technology companies. Is the entrepreneurial motor of the US seizing up? Helen Avery reports.

NOVEMBER WAS A record month for the US IPO market, indicating a return to normality. The question is, what is normality? The number of late-stage technology companies or small-cap companies going public has dramatically decreased in the US. They are turning elsewhere for financing, but what will be the price for the US economy?

The good news is that the US IPO market is back. After a slow start in 2010 in terms of deal size, by November 19 about $18.5 billion had been raised, with more deals expected. With the forecast IPOs, ­November looked set to deliver the largest dollar value of new-issue equity capital raised in the US in a single month.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of acces below.

SUBSCRIBE ONLINE TODAY

Unlimited access to Euromoney.com and Asiamoney.com

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£68.33 per month

Billed Annually

FREE 7 DAY TRIAL

Unlimited access to Euromoney.com and Asiamoney.com, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors

LOGIN NOW

Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree